Industry Prospects Favor Alcon Per a report by MarketsandMarkets, the global intraocular lens market was valued at $4.0 billion in 2022 and is forecasted to grow at a robust compound annual rate ...

1,2,13-19,* This allowed for specific enhancements while maintaining the features that have driven the success of PanOptix—the world’s most implanted trifocal IOL." 3-5,‡ "PanOptix ... 11,20 "I was ...

GENEVA, April 02, 2025--Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter GENEVA, March 26, 2025--Alcon ...

Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology ...

PanOptix Pro will be the first presbyopia-correcting IOL available in the U.S. from Alcon in the single-use Clareon AutonoMe® preloaded delivery system. PanOptix Pro will also be available for ...

Alcon Inc. ALC recently introduced the Clareon PanOptix Pro intraocular lens (IOL) for cataract patients in the United States. PanOptix Pro leverages proprietary ENLIGHTEN NXT Optical technology to ...